372건 · 관련도순
Determine whether an app is ready to submit, then drive the current App Store release flow with asc, including validation, staging, review submission, first-time availability, subscriptions, IAP, Game Center, and App Privacy checks.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Automate Cal.com tasks via Rube MCP (Composio): manage bookings, check availability, configure webhooks, and handle teams. Always search tools first for current schemas.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Automates SOC 2 Type II audit preparation including gap assessment against AICPA Trust Services Criteria (CC1-CC9), evidence collection from cloud providers and identity systems, control testing validation, remediation tracking, and continuous compliance monitoring. Covers all five TSC categories (Security, Availability, Processing Integrity, Confidentiality, Privacy) with automated evidence gathering from AWS, Azure, GCP, Okta, GitHub, and Jira. Use when preparing for or maintaining SOC 2 Ty...
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Expert database administrator specializing in high-availability systems, performance optimization, and disaster recovery. Masters PostgreSQL, MySQL, MongoDB, and Redis with focus on reliability, scalability, and operational excellence.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Generates creative domain name ideas for your project and checks availability across multiple TLDs (.com, .io, .dev, .ai, etc.). Saves hours of brainstorming and manual checking.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Drug regulatory and approval research — FDA substance registry, ATC/EPC classification, EMA decisions, generic-drug status, FDA Orange Book exclusivity, NDA/BLA pathways. Use for jurisdiction-aware approval status (FDA vs EMA), generic vs brand availability, exclusivity expiry tracking, and regulatory pathway selection. Always specifies the market when reporting status.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Comprehensive ADMET (Absorption, Distribution, Metabolism, Excretion, Toxicity) profiling for drug candidates. Integrates ADMET-AI predictions, SwissADME drug-likeness, PubChemTox experimental toxicity, ChEMBL clinical data, Lipinski rule-of-five, and CYP interaction data. Use for drug-likeness assessment, BBB penetration, bioavailability, hepatotoxicity prediction, ADME/PK profiling, or screening compound libraries before lab testing.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Find commercial sources for chemical compounds — PubChem/ChEMBL identity resolution then vendor catalog search across ZINC, Enamine, eMolecules, Mcule. Compares pricing, availability, and identifies purchasable analogs when an exact compound is not in stock. Use for chemical procurement, virtual library curation, and 'where can I buy X' questions for synthesis planning.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Performs retrosynthetic planning using AiZynthFinder (MCTS, template-based), Chemformer (template-free transformer), ASKCOS, and emerging RetroSynFormer with explicit handling of route scoring, building-block availability (eMolecules, Enamine, Mcule), forward prediction validation (Molecular Transformer), and disconnection-aware multi-objective search (MO-MCTS). Use when assessing synthetic feasibility of generated or selected molecules, planning multi-step syntheses, building synthesis-aware design pipelines, or screening libraries for retro-route feasibility.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Extract SKUs, product names, unit prices, availability, and minimum order quantities from a supplier catalog page.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Extract product name, price, availability, description, and specifications from a public product page.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Book reservations through Google Maps using browser automation. Searches for businesses, checks availability, and completes bookings via "Reserve with Google" or 3rd-party providers (OpenTable, Resy, Vagaro). Supports restaurants (primary), salons, fitness, healthcare. Use when user wants to book, reserve, or schedule at a business found on Google Maps.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Draft or review an employer's Otameshi Tenshoku listing so a candidate can decide whether to apply: check item by item that the work, deliverable, out-of-scope tasks, required experience, support, hours, schedule, location, compensation, contract form and payment timing are stated, find open-ended, unpaid-company-work, guarantee, personal-attribute and unverifiable wording, and confirm that the hours, weekly availability, period, rate and budget hold together. Use when a hiring manager, recruiter or small-business owner wants a listing written from a plan, wants an existing draft or published listing reviewed before or after posting, or wants to know why applications are not coming; do not use to design the work itself (trial-work-design), to reply to applicants (applicant-reply), to state market rates, legal, tax or service conditions from memory, or to post or update the listing on the user's behalf.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Corrects the gene-independent copy-number artifact in CRISPR-Cas9 screens (Aguirre 2016 / Munoz 2016 Cancer Discov) where amplified loci appear essential from DNA-damage burden of simultaneous cuts. Covers the p53-dependent G2-arrest mechanism, CRISPRcleanR (Iorio 2018) unsupervised pre-hoc correction, CERES (Meyers 2017) joint CN + gene-effect model, Chronos (Dempster 2021) DepMap-standard population-dynamics + CN model with lowest residual bias, the decision tree by data availability, the Spearman LFC-vs-CN diagnostic, focal-amplification examples (ERBB2 in HER2+, MYC in colorectal, FGFR1 in head and neck), and CRISPRi/a alternatives that bypass the artifact. Use when screening cancer cell lines, diagnosing essentiality at amplified loci, choosing CRISPRcleanR / CERES / Chronos, deciding whether CN correction is needed before MAGeCK / BAGEL2 / drugZ, or switching from Cas9 to CRISPRi.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Performs retrosynthetic planning using AiZynthFinder (MCTS, template-based), Chemformer (template-free transformer), ASKCOS, and emerging RetroSynFormer with explicit handling of route scoring, building-block availability (eMolecules, Enamine, Mcule), forward prediction validation (Molecular Transformer), and disconnection-aware multi-objective search (MO-MCTS). Use when assessing synthetic feasibility of generated or selected molecules, planning multi-step syntheses, building synthesis-aware design pipelines, or screening libraries for retro-route feasibility.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Audit required bioinformatics command-line tools against Lmod or Environment Modules on Linux HPC clusters, resolve executable and version requirements, and reproducibly deploy missing software through a site-approved EasyBuild, Spack, Bioconda/micromamba, Apptainer, binary, or source-build workflow. Use when Codex must inspect module availability, diagnose a missing or wrong-version bioinformatics tool, install scientific software on Slurm/PBS clusters, publish or validate modulefiles, or produce an auditable and rollback-ready cluster software deployment.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Extract study sites, observational variables, coordinates, climate-forcing sources, and cited data sources from ecosystem-modeling papers, PDFs, supplements, or article text, then plan or create EcoSIM simulation workflows and run folders for those sites. Use when Codex is asked to read a paper for EcoSIM feasibility, including requests phrased as "read paper for ecosim feasibility"; read a paper for sites/data availability; reproduce a published site simulation in EcoSIM; compare EcoSIM outputs to paper observations; or convert paper-derived AmeriFlux, FLUXNET, US NLDAS-domain, non-US ERA5, crop, peatland, forest, grassland, wetland, or unmanaged field-site information into EcoSIM inputs and runnable cases.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Passive domain reconnaissance using Python stdlib. Subdomain discovery, SSL certificate inspection, WHOIS lookups, DNS records, domain availability checks, and bulk multi-domain analysis. No API keys required.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Recommend context-appropriate QA tools while preserving observed availability, constraints, and safer alternatives.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Find the right skill for a capability. Load when a user or skill needs to check if a skill exists for a given task, when process-decomposer assigns skills to steps, or when agent-builder checks skill availability. Triggers on "what skill does this need", "find a skill for", "is there a skill that", "which skill handles", "does a skill exist for", "skill lookup", "check skill library". Prevents skill sprawl by always checking existing skills before creating new ones. The gatekeeper for all skill creation.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Generates creative domain name ideas for your project and checks availability across multiple TLDs (.com, .io, .dev, .ai, etc.). Saves hours of brainstorming and manual checking.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Automate Cal.com tasks via Rube MCP (Composio): manage bookings, check availability, configure webhooks, and handle teams. Always search tools first for current schemas.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Automate Calendly scheduling, event management, invitee tracking, availability checks, and organization administration via Rube MCP (Composio). Always search tools first for current schemas.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Corrects the gene-independent copy-number artifact in CRISPR-Cas9 screens (Aguirre 2016 / Munoz 2016 Cancer Discov) where amplified loci appear essential from DNA-damage burden of simultaneous cuts. Covers the p53-dependent G2-arrest mechanism, CRISPRcleanR (Iorio 2018) unsupervised pre-hoc correction, CERES (Meyers 2017) joint CN + gene-effect model, Chronos (Dempster 2021) DepMap-standard population-dynamics + CN model with lowest residual bias, the decision tree by data availability, the Spearman LFC-vs-CN diagnostic, focal-amplification examples (ERBB2 in HER2+, MYC in colorectal, FGFR1 in head and neck), and CRISPRi/a alternatives that bypass the artifact. Use when screening cancer cell lines, diagnosing essentiality at amplified loci, choosing CRISPRcleanR / CERES / Chronos, deciding whether CN correction is needed before MAGeCK / BAGEL2 / drugZ, or switching from Cas9 to CRISPRi.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.